Skip to content
Search

Latest Stories

CPCF negotiations delay sparks ‘deep anger and frustration’ among pharmacy owners

CPE expresses ‘intense anger and frustration’ over continued delay in CPCF negotiations
gettyimages

CPE demands that urgent funding be released into the sector, even before CPCF negotiations are concluded

Community Pharmacy England (CPE) has called on ministers to provide immediate funding relief to the sector while cautioning about the consequences of the continued delay in recommencing the Community Pharmacy Contractual Framework (CPCF) negotiations.

In a ‘strongly worded’ letter to ministers, CPE chief executive Janet Morrison described the intensity of the crisis facing community pharmacies due to chronic underfunding and the severe consequences for patients and communities.


She warned that without urgent remedial action, pharmacy closures will continue and there will not be a community pharmacy sector left to deliver the Contractual Framework, let alone the future ambitions of the government and the NHS.

Morrison said: “We are now eight months into the 2024/25 financial year with no financial settlement in sight: this is disastrous from a business planning perspective, falls short of proper economic regulation, and the continuation of current underfunding is proving catastrophic for community pharmacies.

“I have written to ministers once again to warn them that with every day that passes, more community pharmacies are falling into debt and administration.”

The letter followed the November meeting of the Community Pharmacy England Committee in London, where members expressed “severe frustration and intense anger” about the fact that the government has yet to recommence negotiations whilst pharmacy businesses are “teetering on the edge.”

In a video message, Morrison gave an update on the latest Committee meeting, CPCF negotiations, the work that CPE is doing, and actions they have taken.

Morrison briefed the committee on her understanding of the delay in recommencing negotiations.

She explained: “The agreement on what we can be offered has got stuck in the negotiations between the department of health finance team and the NHS England finance team.”

“My understanding has been that the biggest challenge has been in terms of them having to settle what could be agreed across all of the NHS priorities, including addressing the additional costs arising from the recent budget statement.”

The committee made it clear that urgent funding must be released into the sector, regardless of whether all negotiations have been concluded.

“If we don't get resolution very soon, it has serious consequences for our staff, for patients and for communities,” Morrison added.

More For You

RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less